ABBV vs WST
By Alex · Tickerpine
AbbVie Inc. vs West Pharmaceutical Services, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | WST |
|---|---|---|
| Price | $295.03 | $416.42 |
| Market cap | $521.50B | $29.01B |
| P/E ratio | 50.7 | 46.7 |
| ROE | — | 21.23% |
| Profit margin | 15.67% | 18.81% |
| Revenue growth | 10.30% | 8.70% |
| Dividend yield | 2.35% | 0.25% |
| Beta | 0.19 | 1.14 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs WST in plain English
- ABBV is the bigger company — about 18.0× the market cap of WST.
- WST is cheaper on earnings (P/E 46.7 vs 50.7).
- ABBV is growing revenue faster (10% vs 9%).
- ABBV has the higher dividend yield (2.35% vs 0.25%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
WST return calculator
See what $1,000 in West Pharmaceutical Services, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.